Sebastien Foulquier (S.)

Grzymala, B., Halldorsdottir, D. T., Thorsteinsso, H., Thorfinnsdottir, K., Sveinsdottir, H. S., Parker, M. O., Foulquier, S., & Karlsson, K. AE. (2026). Reinventing amlodipine. Journal of Pharmacology and Experimental Therapeutics, 393(6), Article 104900. https://doi.org/10.1016/j.jpet.2026.104900

Berends, E., Eussen, S. J. P. M., Backes, W. H., Dagnelie, P. C., Jansen, J. F. A., Galan, B. E. D., Greevenbroek, M. M. J. V., Kohler, S., Schram, M. T., Wesselius, A., Oostenbrugge, R. J., Foulquier, S., & Schalkwijk, C. G. (2026). Associations between methylglyoxal and cerebral small vessel disease and cognitive function-The Maastricht Study. Journal of Stroke & Cerebrovascular Diseases, 35(3), Article 108578. https://doi.org/10.1016/j.jstrokecerebrovasdis.2026.108578

Pencheva, M. G., Berends, E., van der Laan, K. W. F., Giudici, A., Niessen, P., Scheijen, J. L. J. M., Vangrieken, P., Leenders, P., Delhaas, T., Caiment, F., Kutmon, M., Trujillo, F. M., Wouters, K., Foulquier, S., Spronck, B., Reesink, K. D., & Schalkwijk, C. G. (2025). Glyoxalase-1 overexpression attenuates arterial wall stiffening in diabetic mice. Cardiovascular Diabetology, 24(1), Article 283. https://doi.org/10.1186/s12933-025-02823-4

Van der Taelen, L., Briones, A. M., Unger, T., Staals, J., van Oostenbrugge, R. J., & Foulquier, S. (2025). Circulating immune cells in cerebral small vessel disease: a systematic review. Biogerontology, 26(3), Article 101. https://doi.org/10.1007/s10522-025-10250-x

Lambrichts, S. M. P., van Oostenbrugge, R. J., & Foulquier, S. (2025). TRPV4 in Cerebral Small Vessel Disease: A key interacting partner. Vascular Pharmacology, 159, Article 107492. https://doi.org/10.1016/j.vph.2025.107492

Berends, E., Vangrieken, P., Amiri, N., van de Waarenburg, M. P. H., Scheijen, J. L. J. M., Hermes, D. J. H. P., Wouters, K., van Oostenbrugge, R. J., Schalkwijk, C. G., & Foulquier, S. (2025). Increased Levels of Circulating Methylglyoxal Have No Consequence for Cerebral Microvascular Integrity and Cognitive Function in Young Healthy Mice. Molecular Neurobiology, 62(4), 4190-4202. Article 101148. https://doi.org/10.1007/s12035-024-04552-3

Vangrieken, P., Scheijen, J. L. J. M., Schiffers, P. M. H., van de Waarenburg, M. P. H., Foulquier, S., & Schalkwijk, C. C. G. (2025). Modelling the effects of elevated methylglyoxal levels on vascular and metabolic complications. Scientific Reports, 15(1), Article 6025. https://doi.org/10.1038/s41598-025-90661-5

Manukjan, N., Fulton, D., Ahmed, Z., Blankesteijn, W. M., & Foulquier, S. (2025). Vascular endothelial growth factor: a double-edged sword in the development of white matter lesions. Neural Regeneration Research, 20(1), 191-192. https://doi.org/10.4103/NRR.NRR-D-23-01843

Berends, E., Pencheva, M. G., van de Waarenburg, M. P. H., Scheijen, J. L. J. M., Hermes, D. J. H. P., Wouters, K., van Oostenbrugge, R. J., Foulquier, S., & Schalkwijk, C. G. (2024). Glyoxalase 1 overexpression improves neurovascular coupling and limits development of mild cognitive impairment in a mouse model of type 1 diabetes. Journal of Physiology, 602(22), 6209-6223. https://doi.org/10.1113/JP286723

Manukjan, N., Chau, S., Caiment, F., van Herwijnen, M., Smeets, H. J., Fulton, D., Ahmed, Z., Blankesteijn, W. M., & Foulquier, S. (2024). Wnt7a Decreases Brain Endothelial Barrier Function Via β-Catenin Activation. Molecular Neurobiology, 61(7), 4854-4867. https://doi.org/10.1007/s12035-023-03872-0